Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Germany
Questran Light 4g/sachet Powder for Oral Suspension.
| Pharmaceutical Form |
|---|
|
Powder for oral administration. |
Each sachet contains 4g anhydrous colestyramine (a basic anion-exchange resin).
Excipient with known effect: Questran Light contains 30mg of aspartame per sachet.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Colestyramine |
Colestyramine resin absorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the faeces. This results in an increased faecal loss of bile acids which leads to an increased oxidation of cholesterol to bile acids and a decrease in serum cholesterol levels and low density lipoprotein serum levels. |
| List of Excipients |
|---|
|
Aspartame |
Original packs containing 50 or 60 laminate sachets composed of paper, polyethylene and aluminium.
Not all pack sizes may be marketed.
CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Germany
PL 27041/0020
25th July 1988 / 26th November 1998
| Drug | Countries | |
|---|---|---|
| QUESTRAN | Australia, Brazil, Germany, Estonia, Finland, France, Ireland, Japan, Netherlands, New Zealand, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
